Importance Multiple myeloma is a hematologic malignancy characterized by presence of
abnormal clonal plasma cells in the bone marrow, with potential for uncontrolled growth …

Multiple myeloma, the most common bone malignancy, is occurring with increasing
frequency in older persons. Typical symptoms are bone pain, malaise, anemia, renal …

Multiple myeloma accounts for 1.6% of all cancer cases and approximately 10% of
hematologic malignancies in the United States. In 2015, an estimated 28,850 new cases of …

Background Multiple myeloma is a malignant disease of plasma cells with a worldwide
incidence of 6–7 cases per 100 000 persons per year. It is among the 20 most common …

Disease overview: Multiple myeloma accounts for approximately 10% of hematologic
malignancies. Diagnosis: The diagnosis requires 10% or more clonal plasma cells on bone …

Disease overview Multiple myeloma accounts for approximately 10% of hematologic
malignancies. Diagnosis The diagnosis requires 10% or more clonal plasma cells on bone …

Disease overview: Multiple myeloma accounts for∼ 10% of all hematologic malignancies.
Diagnosis: The diagnosis requires 10% or more clonal plasma cells on bone marrow …

Multiple myeloma accounts for approximately 10% of hematologic malignancies. The
diagnosis requires≥ 10% clonal bone marrow plasma cells or a biopsy proven …

Multiple myeloma accounts for approximately 10% of hematologic malignancies. The
diagnosis requires≥ 10% clonal bone marrow plasma cells or a biopsy proven …

Multiple myeloma (MM) is an incurable clonal B‐cell malignancy with terminally
differentiated plasma cells. It afflicts approximately 55,000 people in the United States. Over …